Testosterone Science

FDA, Regulation and Guidelines

T Time: Women Were First to Put Testosterone Back on FDA’s Agenda. Now It’s Industry’s Turn

Grade Accurate reporting Categories: Testosterone in women >> FDA, regulation and guidelines

Specific Claim Evaluated

No FDA-approved testosterone product for women exists, and the FDA noted that the normal testosterone range in women is poorly defined, with assay variability.

Primary Research Supporting or Contradicting the Claim

The consensus statement finds direct assays highly unreliable in the female range and states that no blood level distinguishes women with and without sexual dysfunction (Davis et al., 2019).

Corrected Evidence-Based Interpretation

Accurate.

Rationale for Grade

The commentary reports the regulatory history and the measurement problems discussed at the workshop correctly. Its statements are consistent with consensus guidance. It does not make clinical benefit claims.

References

  1. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
    Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD."

Post a Comment

Shared Decision Making

Bring the Evidence to Your Next Consultation

Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.